Finding new markers in hemophilia joint damage
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at tissue from joints affected by hemophilia to find new markers that could help understand and treat joint damage. It is for people with severe hemophilia who need a joint procedure like a fluid removal, synovectomy, or joint replacement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe hemophilia A or B
- You are scheduled for a joint procedure such as fluid removal, synovectomy, or joint replacement
- You can sign a consent form
- You do not currently have an inhibitor (antibodies that block clotting factor treatment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called KN057 for people with hemophilia A or B, with or without inhibitors, to see if it helps prevent bleeding. It is for people who still have frequent bleeding episodes despite current treatments.
This study looks at how people with inherited bleeding disorders, like hemophilia, do after joint replacement surgery. Researchers want to learn what works best for managing bleeding during and after surgery to improve recovery.
This study looks at how many adults with moderate or severe hemophilia A have inflammation in their joints (synovitis). It aims to better understand joint health in people with hemophilia A, including those with inhibitors or joint replacements.
This study is looking at how well joint health can be tracked in people with severe hemophilia A who are receiving regular factor VIII treatment. It uses special markers in the blood and ultrasound to check for early joint changes.
This study uses ultrasound to check if thickened joint lining (synovium) in people with severe hemophilia is a sign of active inflammation or just a harmless leftover. It may help doctors decide whether to treat or watch these joints.
This study uses ultrasound to check the health of your joints. It aims to see if people with mild hemophilia have joint problems even without frequent bleeding, which could help guide future treatment.
Hear when a new Hemophilia A and B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.